The Lupus Foundation of America celebrates the 10th anniversary of its national magazine, Lupus Now®, the only national publication devoted to addressing the complexities of living with lupus. The 10th anniversary issue introduces a new format with more concise reporting on advances in lupus research and treatment, wellness features, clinical updates, and inspiring personal stories.
Lupus Now magazine editor Jenny Thorn Palter and Lupus Foundation of America President & CEO Sandra C. Raymond talk about the tenth anniversary of the only national publication devoted to helping people deal with the complexities of lupus.
Children with lupus may have a higher risk for developing cancer – especially blood cancers such as non-Hodgkin’s lymphoma and leukemia – compared to children without lupus.
By investing in the Lupus Foundation of America, your donation, no matter the gift size, is being put to work. Read more from Donna Grogan, Vice President of Development and Fundraising.
Kim Cantor, Lupus Foundation of America’s Senior Director of Public Policy and Government Relations, discusses the Foundation’s Medicare for Patients RX (MAPRx) Coalition
Dr. Gary Gilkeson of the Medical University of South Carolina discusses his Lupus Foundation of America funded study on the potential use of human mesenchymal stem cells as a therapy for lupus.
In her Expert Column, Dr. Joan T. Merrill, Medical Director, explains why antimalarial medicines are now used to treat lupus.
A new study that analyzed lupus treatment data from past global clinical trials suggests that when testing new drugs in combination with other background therapies, clinical trials should be designed to account for the effects that initial disease activity and background drug treatment have been shown to have on planned endpoints, like response and flare rates.